If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
risk factor |
total |
17
|
24
|
283
|
34
|
25
|
17
|
391
|
Gene and significance breakdown #
Total genes and gene combinations: 40
Gene or gene combination |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
risk factor |
total |
RET
|
16
|
16
|
249
|
33
|
24
|
16
|
345
|
LOC106736614, RET
|
0 |
0 |
5
|
0 |
1
|
0 |
6
|
AHNAK
|
0 |
0 |
2
|
0 |
0 |
0 |
2
|
POLR2F, SOX10
|
0 |
2
|
0 |
0 |
0 |
0 |
2
|
C10orf55, PLAU
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
CCR9, LZTFL1
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
CLUH
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
CNTN5
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
CREBBP
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
DENND3
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
DPYD
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
DYNC2H1
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
FAT3
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
FBN1
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
GDNF
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
GFRA1
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
GLI3
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
IHH
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
IRAK3
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
KDR
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
LOC110120882, LOC110120883, LOC126863146, LOC130067396, POLR2F, SOX10
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
LOC110121502, MCS+9.7, RET
|
0 |
0 |
0 |
0 |
0 |
1
|
1
|
LRBA
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
NAV2
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
NCLN
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
NOTCH2
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
NRP2
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
NTF3
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
NUP98
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
OR1F1
|
0 |
0 |
0 |
1
|
0 |
0 |
1
|
PCDHA1, PCDHA10, PCDHA11, PCDHA12, PCDHA13, PCDHA2, PCDHA3, PCDHA4, PCDHA5, PCDHA6, PCDHA7, PCDHA8, PCDHA9, PCDHA@, PCDHAC1, PCDHAC2, PCDHACT
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
PGRMC2
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
PTCH1
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
SEMA3D
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
SERPINF1
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
TBATA
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
TGFB2
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
THBS4
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
TSC2
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
ZHX2
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
Submitter and significance breakdown #
Submitter |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
risk factor |
total |
Baylor Genetics
|
9
|
0 |
188
|
0 |
0 |
0 |
197
|
Illumina Laboratory Services, Illumina
|
0 |
0 |
73
|
31
|
23
|
0 |
127
|
OMIM
|
0 |
0 |
0 |
0 |
0 |
17
|
17
|
Department of Genetics, Reproduction and Fetal Medicine., Institute of Biomedicine of Seville (IBIS), University Hospital Virgen del Rocío/CSIC/University of Seville.
|
0 |
0 |
17
|
0 |
0 |
0 |
17
|
Clinical Genetics, Erasmus University Medical Center
|
1
|
2
|
12
|
1
|
0 |
0 |
16
|
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
|
6
|
3
|
1
|
1
|
1
|
0 |
12
|
Centre for Genomic Sciences, University of Hong Kong
|
0 |
4
|
0 |
0 |
0 |
0 |
4
|
MGZ Medical Genetics Center
|
0 |
2
|
1
|
0 |
0 |
0 |
3
|
U955 Equipe 11, INSERM
|
1
|
2
|
0 |
0 |
0 |
0 |
3
|
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
|
0 |
2
|
0 |
0 |
0 |
0 |
2
|
HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology
|
1
|
0 |
1
|
0 |
0 |
0 |
2
|
Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center
|
0 |
0 |
0 |
1
|
1
|
0 |
2
|
MVZ Medizinische Genetik Mainz
|
0 |
1
|
1
|
0 |
0 |
0 |
2
|
Intergen, Intergen Genetics and Rare Diseases Diagnosis Center
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics
|
0 |
0 |
0 |
0 |
0 |
1
|
1
|
Diagnostics Division, CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Daryl Scott Lab, Baylor College of Medicine
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Equipe Genetique des Anomalies du Developpement, Université de Bourgogne
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Genetics and Molecular Pathology, SA Pathology
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Genomic Medicine Lab, University of California San Francisco
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
Johns Hopkins Genomics, Johns Hopkins University
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Neuberg Centre For Genomic Medicine, NCGM
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
Genomics England Pilot Project, Genomics England
|
0 |
1
|
0 |
0 |
0 |
0 |
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. Neither the University of Utah nor the National
Institutes of Health independently verfies the submitted
information. If you have questions about the information
contained on this website, please see a health care
professional.